BridgeMD
New treatment option for Post-stroke Patient in Acute, Sub-acute Phase or Chronic
Official title The Effects of Muscle Vibration on the Development of Spasticity and Neuroplasticity in a Post-stroke Population
ClinicalTrials.gov ID: NCT05315726
What this study is testing
- What it's testing
- Several studies have recently tested the use of muscle vibration for the rehabilitation of patients after a stroke. When applied in a repeated and focused manner, this vibration appears to promote the recovery of functional capacities through the mechanisms of neuromuscular plasticity.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Phase 1:
- Adult patient,
- Medically stable on medical assessment, with no contraindications to stroke rehabilitation management management (no medical problems or acute...
- Have had an ischemic and/or hemorrhagic stroke (\> 3 months post-stroke), impacting the motor skills of the upper limbs,
- 1 ≤ MAS \< 4 on elbow or wrist flexors,
You likely can't join if
- Phases 1 and 2:
- Significant pain on mobilization of the wrist or elbow (VAS \> 5/10),
- Presence of other neurological, muscular or osteoarticular conditions altering upper limb function,
- Apparent wound, which may postpone inclusion, or very fragile skin,
- Significant cognitive impairments: inability to understand simple instructions or give consent of any kind (not included if: LAST scores \< 5/7 in...
- Not covered by national health insurance,
See the full eligibility criteria
- Phase 1:
- Adult patient,
- Medically stable on medical assessment, with no contraindications to stroke rehabilitation management management (no medical problems or acute intercurrent medical events),
- Have had an ischemic and/or hemorrhagic stroke (\> 3 months post-stroke), impacting the motor skills of the upper limbs,
- 1 ≤ MAS \< 4 on elbow or wrist flexors,
- Having given oral consent. Phase 2:
- Adult patient \> 18 years old,
- Able to follow a rehabilitation program on medical opinion (no medical issues or acute intercurrent medical events),
- First stroke ever \< 6 weeks, confirmed by imaging,
- Hemiparesis or hemiplegia of the upper limb (FMA-UE score \< 48), particularly in the wrist and elbow flexors,
- Requiring inpatient or outpatient hospitalization in a rehabilitation center,
- Having given oral consent.
- Phases 1 and 2:
- Significant pain on mobilization of the wrist or elbow (VAS \> 5/10),
- Presence of other neurological, muscular or osteoarticular conditions altering upper limb function,
- Apparent wound, which may postpone inclusion, or very fragile skin,
- Significant cognitive impairments: inability to understand simple instructions or give consent of any kind (not included if: LAST scores \< 5/7 in comprehension, and if YES/NO answers are unreliable),
- Not covered by national health insurance,
- Being pregnant or breastfeeding,
- Being under guardianship or curatorship.
- Person subject to a measure of legal protection
The study team makes the final eligibility decision.
Where it's taking place
- Chalon-sur-Saône, France
- Dijon, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chalon-sur-Saône, France; Dijon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.